Deseret Mutual Benefit Administrators’s Regeneron Pharmaceuticals REGN Stock Holding History

Deseret Mutual Benefit Administrators’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$895K	Buy	1,158 +414	+56%	+$317K	0.3%	65
2025 Q4	$574K	Buy	744 +63	+9%	+$42.8K	0.24%	65
2025 Q3	$383K	Buy	681 +106	+18%	+$59.9K	0.16%	81
2025 Q2	$302K	Hold	575	–	–	0.14%	95
2025 Q1	$365K	Sell	575 -46	-7%	-$31.6K	0.18%	78
2024 Q4	$442K	Buy	621 +12	+2%	+$10.1K	0.22%	65
2024 Q3	$640K	Sell	609 -13	-2%	-$14.5K	0.33%	48
2024 Q2	$654K	Sell	622 -6	-1%	-$5.82K	0.3%	51
2024 Q1	$604K	Buy	628 +6	+1%	+$5.71K	0.3%	53
2023 Q4	$546K	Sell	622 -199	-24%	-$164K	0.32%	54
2023 Q3	$676K	Sell	821 -55	-6%	-$43.2K	0.33%	51
2023 Q2	$629K	Buy	876 +86	+11%	+$66.3K	0.24%	57
2023 Q1	$649K	Buy	790 +76	+11%	+$57.3K	0.26%	55
2022 Q4	$515K	Sell	714 -238	-25%	-$176K	0.21%	65
2022 Q3	$656K	Buy	952 +112	+13%	+$70.5K	0.18%	78
2022 Q2	$497K	Buy	840 +293	+54%	+$190K	0.11%	123
2022 Q1	$382K	Buy	547 +259	+90%	+$164K	0.08%	173
2021 Q4	$182K	Buy	288 +26	+10%	+$16K	0.03%	282
2021 Q3	$159K	Hold	262	–	–	0.03%	290
2021 Q2	$146K	Buy	+262	New	+$133K	0.04%	267

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Deseret Mutual Benefit Administrators's REGN Position: Q1 2026 in Review

Deseret Mutual Benefit Administrators increased its Regeneron Pharmaceuticals (REGN) stake by 56% in Q1 2026, buying an estimated $317K and bringing the position to 1,158 shares worth $895K. The position accounts for 0.3% of the portfolio, ranked #65.

Deseret Mutual Benefit Administrators first reported a position in REGN in Q2 2021 and has held it in 20 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Deseret Mutual Benefit Administrators held 1,158 shares of Regeneron Pharmaceuticals worth $895K as of Q1 2026.
Deseret Mutual Benefit Administrators bought 414 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $317K.
Regeneron Pharmaceuticals made up 0.3% of Deseret Mutual Benefit Administrators's portfolio in Q1 2026, its #65 holding.
Deseret Mutual Benefit Administrators first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q1 2026, filed 8 May 2026.